Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria
- PMID: 24898678
- DOI: 10.1111/all.12370
Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria
Abstract
This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2) LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS) and is published in Allergy 2014; 69:868-887.
Keywords: angioedema; consensus; diagnosis; hives; wheal.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.Allergy. 2014 Jul;69(7):868-87. doi: 10.1111/all.12313. Epub 2014 Apr 30. Allergy. 2014. PMID: 24785199
-
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.Allergy. 2018 Jul;73(7):1393-1414. doi: 10.1111/all.13397. Allergy. 2018. PMID: 29336054
-
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria.Allergy. 2006 Mar;61(3):316-20. doi: 10.1111/j.1398-9995.2005.00964.x. Allergy. 2006. PMID: 16436140 Review.
-
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria.Allergy. 2009 Oct;64(10):1417-1426. doi: 10.1111/j.1398-9995.2009.02179.x. Allergy. 2009. PMID: 19772512
-
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.Allergy. 2022 Mar;77(3):734-766. doi: 10.1111/all.15090. Epub 2021 Oct 20. Allergy. 2022. PMID: 34536239
Cited by
-
Cutaneous mastocytosis treatment: strategies, limitations and perspectives.Postepy Dermatol Alergol. 2018 Dec;35(6):541-545. doi: 10.5114/ada.2018.77605. Epub 2018 Aug 13. Postepy Dermatol Alergol. 2018. PMID: 30618520 Free PMC article. Review.
-
Omalizumab Reduces Unplanned Healthcare Interactions in Irish Patients With Chronic Spontaneous Urticaria.Front Allergy. 2021 Dec 23;2:810418. doi: 10.3389/falgy.2021.810418. eCollection 2021. Front Allergy. 2021. PMID: 35387063 Free PMC article.
-
Periostin and Interleukin-13 Are Independently Related to Chronic Spontaneous Urticaria.Allergy Asthma Immunol Res. 2016 Sep;8(5):457-60. doi: 10.4168/aair.2016.8.5.457. Allergy Asthma Immunol Res. 2016. PMID: 27334784 Free PMC article.
-
Triggering atrial fibrillation after omalizumab injection in a patient with chronic spontaneous urticarial. A case report.Med Pharm Rep. 2019 Jan;92(1):91-93. doi: 10.15386/cjmed-1082. Epub 2019 Jan 15. Med Pharm Rep. 2019. PMID: 30957094 Free PMC article.
-
Cutaneous mastocytosis in childhood.Allergol Select. 2022 Jan 5;6:1-10. doi: 10.5414/ALX02304E. eCollection 2022. Allergol Select. 2022. PMID: 35028497 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical